The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BioLineRx; Sapience Therapeutics
Leadership - BioLineRx; Sapience Therapeutics
Stock and Other Ownership Interests - BioLineRx; Sapience Therapeutics
Honoraria - BioLineRx; Sapience Therapeutics
Consulting or Advisory Role - BioLineRx; GalMed Pharmacueticals
Research Funding - BioLineRx; Sapience Therapeutics
Patents, Royalties, Other Intellectual Property - BioLineRx
Travel, Accommodations, Expenses - BioLineRx; Sapience Therapeutics
Other Relationship - BioLineRx; Sapience Therapeutics
Efficacy and biomarker analysis of phase 2 (P2) and window-of-opportunity (WoO) cohorts of patients with recurrent glioblastoma (rGBM) treated with ST101, an inhibitor of the transcription factor C/EBPβ.
 
Fabio Massaiti Iwamoto
Stock and Other Ownership Interests - Praesidia Biotherapeutics
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Anheart Therapeutics; ClearView Healthcare Partners; Gennao Bio; Guidepoint Global; Kiyatec; Massive Bio; Medtronic; Merck; MimiVax; Novocure; Ono Pharmaceutical; PPD; Praesidia Biotherapeutics; Regeneron; tocagen; Xcures
Speakers' Bureau - Prime Oncology
Research Funding - ABM (Inst); Anheart Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); FORMA Therapeutics (Inst); Merck (Inst); Northwest Biotherapeutics (Inst); Novocure (Inst); Pfizer (Inst); Sapience Therapeutics (Inst); tocagen (Inst)
Travel, Accommodations, Expenses - Oncoceutics
(OPTIONAL) Uncompensated Relationships - Northwest Biotherapeutics
 
Abi Vainstein Haras
No Relationships to Disclose
 
Jim Rotolo
Employment - Sapience Therapeutics
Stock and Other Ownership Interests - Sapience Therapeutics
Patents, Royalties, Other Intellectual Property - Hold patents and have patents pending from discoveries and technology generated at Sapience Therapeutics
Travel, Accommodations, Expenses - Sapience Therapeutics
 
Clara Levrero
No Relationships to Disclose
 
Eyal Shaich
Employment - Bioforum Group
Consulting or Advisory Role - Abiomed; Axogen Inc; Ayala Pharmaceuticals; Sapience Therapeutics
 
Osama Al Dalahmah
Stock and Other Ownership Interests - GE Healthcare
Research Funding - Sapience Therapeutics
 
Robin Arthur Buerki
Consulting or Advisory Role - Guidepoint Global; Mosaic Research Management; techspert.io